Article Details
Retrieved on: 2021-06-15 07:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
US-based biotechnology company Novavax 's protein-based vaccine has shown overall 90 per cent efficacy against Covid-19, results of Phase-3 ...
Article found on: www.businessinsider.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here